| 51 |
28087699 | Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase. | 2017 Mar 3 |
1 |
| 52 |
28279034 | [Clinical significance of cytogenetic monitoring in chronic myeloid leukemia]. | 2017 Feb 14 |
1 |
| 53 |
28288113 | Germline mutations in ABL1 cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations. | 2017 Apr |
1 |
| 54 |
28378189 | Cleavage and phosphorylation: important post-translational modifications of galectin-3. | 2017 Jun |
1 |
| 55 |
28428613 | Differential regulation of PKD isoforms in oxidative stress conditions through phosphorylation of a conserved Tyr in the P+1 loop. | 2017 Apr 20 |
1 |
| 56 |
28486134 | Abl Regulates Planar Polarized Junctional Dynamics through β-Catenin Tyrosine Phosphorylation. | 2017 May 8 |
1 |
| 57 |
28578803 | Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin. | 2017 Sep |
2 |
| 58 |
28666867 | Enhancement of TGF-β-induced Smad3 activity by c-Abl-mediated tyrosine phosphorylation of its coactivator SKI-interacting protein (SKIP). | 2017 Aug 26 |
1 |
| 59 |
29022905 | c-Abl-mediated Drp1 phosphorylation promotes oxidative stress-induced mitochondrial fragmentation and neuronal cell death. | 2017 Oct 12 |
1 |
| 60 |
29066624 | Active site-adjacent phosphorylation at Tyr-397 by c-Abl kinase inactivates caspase-9. | 2017 Dec 29 |
5 |
| 61 |
26866052 | Expression, purification, crystallization and X-ray data collection for RAS and its mutants. | 2016 Mar |
2 |
| 62 |
27018250 | Functional interaction between nonreceptor tyrosine kinase c-Abl and SR-Rich protein RBM39. | 2016 Apr 22 |
1 |
| 63 |
27078848 | CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma. | 2016 May 17 |
1 |
| 64 |
27161995 | Parallel Chemical Protein Synthesis on a Surface Enables the Rapid Analysis of the Phosphoregulation of SH3 Domains. | 2016 Jun 13 |
1 |
| 65 |
27228340 | MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells. | 2016 |
1 |
| 66 |
27348587 | Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration. | 2016 Aug 1 |
1 |
| 67 |
27757426 | TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1. | 2016 Apr |
3 |
| 68 |
25043303 | Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity. | 2015 May 14 |
1 |
| 69 |
25082234 | HAUSP compartmentalization in chronic myeloid leukemia. | 2015 Apr |
1 |
| 70 |
25249015 | Grb10 is involved in BCR-ABL-positive leukemia in mice. | 2015 Apr |
2 |
| 71 |
25527332 | The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear. | 2015 Jan |
1 |
| 72 |
25694432 | The interaction of protein-tyrosine phosphatase α (PTPα) and RACK1 protein enables insulin-like growth factor 1 (IGF-1)-stimulated Abl-dependent and -independent tyrosine phosphorylation of PTPα. | 2015 Apr 10 |
2 |
| 73 |
25770215 | Role for Tyrosine Phosphorylation of A-kinase Anchoring Protein 8 (AKAP8) in Its Dissociation from Chromatin and the Nuclear Matrix. | 2015 Apr 24 |
1 |
| 74 |
25795725 | c-Abl mediated tyrosine phosphorylation of paxillin regulates LPS-induced endothelial dysfunction and lung injury. | 2015 May 15 |
2 |
| 75 |
25821558 | HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells. | 2015 Jan |
1 |
| 76 |
25999467 | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 2015 Sep |
3 |
| 77 |
26126715 | The kinase ABL phosphorylates the microprocessor subunit DGCR8 to stimulate primary microRNA processing in response to DNA damage. | 2015 Jun 30 |
2 |
| 78 |
26134485 | Site Selective Azo Coupling for Peptide Cyclization and Affinity Labeling of an SH3 Protein. | 2015 Aug 19 |
1 |
| 79 |
26217035 | c-Abl-mediated tyrosine phosphorylation of JunB is required for Adriamycin-induced expression of p21. | 2015 Oct 1 |
4 |
| 80 |
26235616 | c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells. | 2015 Aug 11 |
1 |
| 81 |
26310847 | Novel roles for LIX1L in promoting cancer cell proliferation through ROS1-mediated LIX1L phosphorylation. | 2015 Aug 27 |
1 |
| 82 |
26697169 | Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier function. | 2015 Dec |
2 |
| 83 |
23542172 | The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer. | 2014 Mar 13 |
1 |
| 84 |
24317448 | BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP. | 2014 Jun |
1 |
| 85 |
24378532 | PLEKHG2/FLJ00018, a Rho family-specific guanine nucleotide exchange factor, is tyrosine phosphorylated via the EphB2/cSrc signaling pathway. | 2014 Apr |
1 |
| 86 |
24412932 | c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. | 2014 Jun 1 |
2 |
| 87 |
24445143 | IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. | 2014 May |
2 |
| 88 |
24455116 | Imatinib in chronic myeloid leukemia: an overview. | 2014 Jan 2 |
1 |
| 89 |
24475245 | Oligomerization and phosphorylation dependent regulation of ArgBP2 adaptive capabilities and associated functions. | 2014 |
1 |
| 90 |
24569990 | Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage. | 2014 Apr 11 |
5 |
| 91 |
24759597 | SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells. | 2014 Jul |
1 |
| 92 |
24786396 | The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease. | 2014 May 2 |
1 |
| 93 |
24836440 | BCR-ABL affects STAT5A and STAT5B differentially. | 2014 |
1 |
| 94 |
24913448 | LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia. | 2014 Jul 30 |
1 |
| 95 |
25201268 | Electrochemical evaluation of Abelson tyrosine-protein kinase 1 activity and inhibition by imatinib mesylate and danusertib. | 2014 Oct 3 |
1 |
| 96 |
25264277 | Exposure of neuroblastoma cell lines to imatinib results in the upregulation of the CDK inhibitor p27(KIP1) as a consequence of c-Abl inhibition. | 2014 Nov 15 |
2 |
| 97 |
22976128 | Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells. | 2013 Mar |
1 |
| 98 |
23233201 | PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells. | 2013 Feb |
2 |
| 99 |
23318434 | Dual regulation of Myc by Abl. | 2013 Nov 7 |
5 |
| 100 |
23325923 | c-Abl tyrosine kinase plays a critical role in β2 integrin-dependent neutrophil migration by regulating Vav1 activity. | 2013 Apr |
2 |